resourceId,strainNomenclature,backgroundStrain,backgroundSubstrain,animalModelGeneticDisorder,animalModelOfManifestation,transplantationType,animalState,generation,donorId,transplantationDonorId,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
RES60a30c1c,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,129T2/SvEmsJ x C57Bl/6NTac,,Neurofibromatosis type 1,,,,,,,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Experimental subjects were 8–12 week old 129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- male and female mice that were generated via the F1 cross,0.95,Accept,Experimental Usage
RES6701a540,C57BL6/J Nf1+/−;Trp53+/−,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,C57BL6/J Nf1+/−;Trp53+/−,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Murine MPNST tumor lines established from C57BL6/J Nf1+/−;Trp53+/− (NPcis) expressing GFP-Luciferase,0.95,Accept,Experimental Usage
RES5c29d488,Nf1 c.5425 C > T ; Arg1809Cys,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Non-tumor forming mutation,,,,,,Nf1 c.5425 C > T ; Arg1809Cys,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Heterozygous Nf1 c.5425 C > T ; Arg1809Cys-mutant mice were generated by CRISPR/Cas9 engineering directly into C57Bl/6J embryos,0.95,Accept,Experimental Usage
RES37d0d0f4,R681X Nf1,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,,R681X Nf1,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,heterozygous R681X and c.3827G > C Nf1-mutant mice were backcrossed to C57Bl/6J,0.9,Accept,Experimental Usage
RESe1e3fe79,Nf1 flox/flox ; Hoxb7-Cre,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,Nf1 flox/flox ; Hoxb7-Cre,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,conditional knockout Nf1 flox/flox ; Hoxb7-Cre mice were used,0.95,Accept,Experimental Usage
RES9aecdcd6,Nf1 f/neo ; hGFAP-Cre,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1 f/neo ; hGFAP-Cre,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Optic glioma-prone mice were generated with the R1809C mutation or a neomycin cassette inserted in exon 31 as the germline Nf1 allele and somatic Nf1 inactivation in neuroglial progenitor cells (Nf1 f/neo ; hGFAP-Cre mice),0.95,Accept,Experimental Usage
RESae80970f,Nf1-IF,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,Nf1-IF,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 inframe indel (Nf1-IF) rats have a 54bp deletion in exon 20,0.95,Accept,Experimental Usage
RES95b54f21,Nf1-PS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,Nf1-PS,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 premature stop indel (Nf1-PS) rats have an 8-bp deletion in exon 20,0.95,Accept,Experimental Usage
RES3a69c7aa,Nf1-IFPS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,,Nf1-IFPS,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 in-frame premature stop indel (Nf1-IFPS) rats have a 57-bp deletion in exon 20,0.95,Accept,Experimental Usage
RES316daddd,Nf1(ob) (-/-),,,Neurofibromatosis type 1,Bone healing defects,,,,,,Nf1(ob) (-/-),PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,we assessed bone healing in the Nf1(ob) (-/-) conditional mouse model lacking Nf1 specifically in osteoblasts,0.9,Accept,Experimental Usage
RES73ca456b,2.3-kb α1(I) collagen-cre Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,,2.3-kb α1(I) collagen-cre Nf1 flox/flox,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,WT and mice were generated by crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice,0.85,Accept,Experimental Usage
RESbf0146a3,Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,,Nf1 flox/flox,PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:28525381 | PMID:25535838 | PMID:21980365 | PMID:29590612 | PMID:20200958 | PMID:24997609,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1371/journal.pone.0024917 | 10.1016/j.celrep.2018.03.014 | 10.1002/jbmr.42 | 10.1038/nm.3583,"Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. | A Conserved Circadian Function for the Neurofibromatosis 1 Gene. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"CX3CR1-CreER [ 71 ] were intercrossed with Nf1 flox/flox [ 1 ] | R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1 | Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background | Nf1 flox/flox mice were provided by Dr. Luis Parada at the University of Texas Southwestern Medical Center | while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established | The control mice for Nf1 hGFAP CKO mice are a pool of phenotypically indistinguishable mice: hGFAP-cre-; Nf1 flox/flox | Nf1flox/flox mice were provided by Dr. Luis Parada at the University of Texas Southwestern Medical Center | Brainstem astrocytes obtained from Nf1 flox/flox mouse pups (postnatal days 1–2) were infected with adenovirus | crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice | WT and Col2-Nf1 KO mice were generated by crossing Nf1 flox/flox mice and Nf1 flox/+ ; α1(II) collagen-Cre breeders",0.95,Accept,Experimental Usage
RESd390084f,Nf1 flox,,,Neurofibromatosis type 1,,,,,,,Nf1 flox,PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:19427294 | PMID:18671844 | PMID:21726432,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1016/j.stem.2009.03.017 | 10.1186/1741-7015-6-21 | 10.1186/1741-7015-9-82,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. | Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox | Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously | The NF1 flox/− mice are in a mixed genetic background of C57BL/6/Sv129 and have been described previously | The Nf1 flox/- mice are in a mixed genetic background of C57BL/6/ Sv129 and have been described previously | The Nf1flox and Prx1Cre lines were maintained by continuous backcrossing to wild-type C57BL/6J mice | The female Nf1flox mice were crossed to male Nf1flox heterozygous Prx1-Cre-positive males",0.95,Accept,Experimental Usage
RESd867fbf0,Nf1+/-,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,,Nf1+/-,PMID:32781282 | PMID:21199799 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:21980365 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1371/journal.pone.0024917 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,"Nf1 heterozygous (Nf1+/-) mice accurately reflect the dominant inheritance of NF1 and are regularly employed as a model of NF1 | Nf1 +/− mice were generated as previously described (11). In brief, Nf1 +/− mice maintained in the 129/Sv background (12) were crossed with wild-type C57Bl/6 mice. | Mice heterozygous for the Nf1 mutation on a background of C57BL/6J were originally developed by Dr. Tyler Jacks | Nf1 heterozygous (Nf1+/–, C57BL/6) mice have been previously described | heterozygous germline knockout mouse model of Neurofibromatosis type 1 (Nf1 ± mice) | R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1 | Nf1+/- and wildtype mice were generated as previously described. In brief, Nf1+/- mice maintained in the 129/Sv background were crossed with wild-type C57Bl/6 mice. | Generation of the...Nf1 (+/- Jacks et al., 1994)...In MNTB principal neurons of Nf1 (+/-) mice the average delay between EPSPs and APs was slightly smaller | Nf1 +/− mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology | Several Nf1 alleles were used in these studies including Nf1 (germline mutant) mice (− Jacks et al., 1994) | Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice | Nf1 +/− mice were obtained from Dr Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA, USA) in a C57BL/6J.129 background and backcrossed for 13 generations into a C57BL/6J strain | Nf1+/− mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) | statin-mediated inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase restores the cognitive deficits in an NF1 mouse model",0.95,Accept,Experimental Usage
RES6e23a044,y w Mer4,,,Neurofibromatosis type 2,,,,,,,y w Mer4,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,"crossed to female flies of the following genotype, y w Mer4",0.9,Accept,Experimental Usage
RES25632977,4/FM7; T80-Gal4 y w Mer4,,,Neurofibromatosis type 2,,,,,,,4/FM7; T80-Gal4 y w Mer4,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,surviving 4/FM7; T80-Gal4 y w Mer4 hemizygous males,0.85,Accept,Experimental Usage
RESe57e7070,PLP CreERT2; Nf1 f/−; ROSA-LacZ,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,PLP CreERT2; Nf1 f/−; ROSA-LacZ,PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,PLP CreERT2; Nf1 f/−; ROSA-LacZ mice was conditionally activated with a single subcutaneous dose of 4-hydroxytamoxifen,0.95,Accept,Experimental Usage
RESe475a58f,Nf1Prx1,,,Neurofibromatosis type 1,limb knock-out,,,,,,Nf1Prx1,PMID:24465906 | PMID:18671844 | PMID:21726432,10.1371/journal.pone.0086115 | 10.1186/1741-7015-6-21 | 10.1186/1741-7015-9-82,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,"we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out) | Mice with conditionally inactivated neurofibromin (Nf1) in the developing limbs and cranium (Nf1Prx1) show bowing of the tibia caused by decreased bone mineralisation | mice bearing conditional inactivation of NF1 in the developing limbs...Nf1Prx1 mouse model might prove to be relevant biomarkers",0.95,Accept,Experimental Usage
RESfd454e78,Nf1+/− GFAP CKO,C57BL/6,,Neurofibromatosis type 1,attention deficit,,,,,,Nf1+/− GFAP CKO,PMID:21963652 | PMID:19191334 | PMID:23225063,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,,Nf1 +/− GFAP CKO (CKO) and control littermate Nf1 flox/flox (WT) mice were maintained on an inbred C57BL/6 background | Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background | Nf1 +/− GFAP CKO (CKO) with one non-functional Nf1 allele in all somatic cells and complete Nf1 loss in GFAP+ (glial) cells,0.95,Accept,Experimental Usage
RES22a66b69,Nf1(flox/-);Col2.3Cre(+),,,Neurofibromatosis type 1,Spinal deformities,,,,,,Nf1(flox/-);Col2.3Cre(+),PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"we report a novel murine NF1 model, Nf1(flox/-);Col2.3Cre(+) mice. These mice display short vertebral segments",0.95,Accept,Development
RES8010fe38,cisNP,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,cisNP,PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"The cisNP mouse model has been previously described (27, 28). | A spontaneous MPNST GEMM, cisNP, was previously described (Vogel et al., 1999)",0.9,Accept,Experimental Usage
RES64a05ee5,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,,,Neurofibromatosis type 1,,,,,,,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The Nf1 mutant fly line was generated by CRISPR/Cas9 using the sgRNA line: y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,0.9,Accept,Experimental Usage
RES01f5e8c7,P{ KK101909 }VIE‐260B,,,Neurofibromatosis type 1,,,,,,,P{ KK101909 }VIE‐260B,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,dNf1 RNAi line: P{ KK101909 }VIE‐260B (VDRC #109637),0.9,Accept,Experimental Usage
RESbb21f572,Nf1Dsk9/+,C3HeB/FeJ x C57bl/6,,Neurofibromatosis type 1,,,,,,,Nf1Dsk9/+,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The NF1 mouse model used in this study has been described elsewhere. Dsk9 is a missense mutation in the GTPase-activating protein related domain of neurofibromin. Nf1Dsk9/+ (subsequently referred to as ""Nf1+/-"") mice were maintained on a mixed (C3HeB/FeJ x C57bl/6) background.",0.95,Accept,Experimental Usage
RESb805ba75,P0SchΔ39-121,,,Neurofibromatosis type 2,,,,,,,P0SchΔ39-121,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"P0SchΔ39-121 transgenic mice were obtained from Riken Bioresource Center (Tsukuba, Japan). P0SchΔ39-121 heterozygous mice express a dominant negative form of merlin",0.95,Accept,Experimental Usage
RES9f0896d4,"Trp53, Nf1, Suz12 triple mutant",,,Neurofibromatosis type 1,tumors,,,,,,"Trp53, Nf1, Suz12 triple mutant",PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"The triple mutant line from the vendor carries Trp53, Nf1, Suz12 mutations on chromosome 11 and develops tumors at approximately four months, which is similar to conditions found in human NF1 patients",0.95,Accept,Experimental Usage
RES971399c4,Nf1flox/flox;PostnCre,C57BL/6 × 129/SV,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,Nf1flox/flox;PostnCre,PMID:33442015 | PMID:31527226 | PMID:37406085 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1158/1078-0432.CCR-22-2854 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,"Genetically engineered Nf1flox/flox;PostnCre mice on a mixed C57BL/6 × 129/SV background were utilized for in vivo studies | The Nf1;flox/flox PostnCre+ mice were developed and bred by the Clapp Laboratory utilizing tools reported previously (18). Tumor formation is driven by the early embryonic conditional deletion of Nf1 in Schwann cell progenitors via the Periostin (Postn) promoter and Cre recombinase enzyme | Genetically engineered Nf1flox/flox;PostnCre mice that develop multiple plexiform neurofibromas along the peripheral nerves were utilized for in vivo studies | Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues | RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice",0.95,Accept,Experimental Usage
RESb8ec4fc0,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,The NPE-mutant mice were generated by crossing NF1 fl/fl (JAX Nf1tm1Par/J) Tp53 fl/fl Eed fl/fl mice with Dhh-Cre mice,0.9,Accept,Experimental Usage
RES136a6220,NF1 R1947/+,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,,NF1 R1947/+,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Generation of NF1 NS/+ minipigs Generation of a swine nonsense mutation model of NF1 followed a similar strategy as previously described. Recurrent nonsense mutation R1947∗ NF1 is located within exon 41,0.95,Accept,Development
RES0178a4cc,Nf1fl/fl,C57BL/6,,Neurofibromatosis type 1,,,,,,,Nf1fl/fl,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage
RESf2783b89,OPG Nf1fl/mut (Nf1+/−),C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,OPG Nf1fl/mut (Nf1+/−),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage
RES644113d0,Nf1 hGFAP CKO,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,Nf1 hGFAP CKO,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"The mutant mice ( Nf1 hGFAP CKO) used were of the genotypes, hGFAP-cre+; Nf1 flox/KO  and hGFAP-cre+; Nf1 flox/flox",0.95,Accept,Experimental Usage
RES5b5f1511,Nf1 NcreER CKO,C57Bl6 and 129Svj,,Neurofibromatosis type 1,,,,,,,Nf1 NcreER CKO,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,Nestin-cre ER +; Nf1 flox/flox  (tamoxifen+) mice were used as mutants ( Nf1 NcreER CKO),0.9,Accept,Experimental Usage
RES4cf34317,Nf1 fcr,C57BL/6,,Neurofibromatosis type 1,,,,,,,Nf1 fcr,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously",0.95,Accept,Experimental Usage
RESf5e1c690,NPcis,C57BL/6,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,NPcis,PMID:38900740 | PMID:36730269 | PMID:17216419,10.1371/journal.pone.0301040 | 10.1371/journal.pone.0277305 | 10.1007/s10048-006-0078-5,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma. | Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,NPcis mouse model developed a malignant version of neurofibroma called malignant peripheral nerve sheath tumor (MPNST) within 3 to 6 months | sporadically developed by the NPcis genetically engineered mouse model. The germline of these mice is heterozygous for Nf1 and Tp53; mutant alleles are located in cis | NPcis mice on the C57BL/6J background were backcrossed greater than 20 generations. NPcis mice on the 129S4/SvJae background were maintained as inbred,0.95,Accept,Experimental Usage
RES9a06a62f,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",C57Bl/6,,Neurofibromatosis type 1,Optic pathway glioma,,,,,,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,"OPG mice (Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO) mice were generated as previously described",0.95,Accept,Experimental Usage
RESbcbdd0d7,Postn-Cre; Nf2flox/flox,FVB/NTac,,Neurofibromatosis type 2,schwannomas,,,,,,Postn-Cre; Nf2flox/flox,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,The Postn-Cre transgenic and conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs at Indiana University School of Medicine,0.95,Accept,Experimental Usage
RES173e403d,Nf2 Flox/Flox,,,Neurofibromatosis type 2,,,,,,,Nf2 Flox/Flox,PMID:25433207 | PMID:41444363 | PMID:24817309,10.1016/j.ydbio.2014.11.017 | 10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development. | Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"The Nf2 line has been described previously (Flox/Flox Giovannini et al., 2000) | conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs | Nf2flox/flox mice carrying a LoxP insertion in the Nf2 gene [13] were maintained at the Washington University School of Medicine",0.95,Accept,Experimental Usage
RES67640ce9,"Dhh::Cre, Nf1fl/fl, Pten",,,Neurofibromatosis type 1,Peripheral nerve sheath tumor,,,,,,"Dhh::Cre, Nf1fl/fl, Pten",PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"The GEMM of high-grade PNSTs was generated as described previously. Dhh::Cre, Nf1fl/fl, Pten experimental class animals were randomized to a treatment or vehicle group",0.9,Accept,Experimental Usage
RESd6ee208c,Nf1 flox/flox; GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic glioma,,,,,,Nf1 flox/flox; GFAP-Cre,PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,"Five-six week-old Nf1 GFAP CKO mice (Nf1 flox/flox; GFAP-Cre) were used. These mice lack Nf1 gene expression in GFAP+ (glial) cells | Nf1^flox/flox;GFAP-Cre mice (OPG mice) were generated as previously described. All mice were maintained on a C57BL/6 background | Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described",0.95,Accept,Experimental Usage
RES41704967,DhhCre;Nf1fl/fl,,,Neurofibromatosis type 1,neurofibroma,,,,,,DhhCre;Nf1fl/fl,PMID:28029918 | PMID:19041782,10.1056/NEJMoa1605943 | 10.1016/j.stem.2008.10.003,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas. | Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,"Selumetinib was evaluated in the DhhCre;Nf1fl/fl genetically engineered mouse model of neurofibroma | +/− DhhCre;Nf1 mice were generated as described ( fl/fl Wu et al., 2008 )",0.95,Accept,Experimental Usage
RES3dbffed8,Nf1Col1,,,Neurofibromatosis type 1,osteoblast specific knock-out,,,,,,Nf1Col1,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out)",0.95,Accept,Experimental Usage
RES5d4d846e,Nf1(fl/fl);DhhCre,,,Neurofibromatosis type 1,Neurofibroma,,,,,,Nf1(fl/fl);DhhCre,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation,0.9,Accept,Experimental Usage
RES1e67bb5c,Stat3(fl/fl);Nf1(fl/fl);DhhCre,,,Neurofibromatosis type 1,Neurofibroma,,,,,,Stat3(fl/fl);Nf1(fl/fl);DhhCre,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,Knockdown of Arid1b or Gsk3β in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation,0.9,Accept,Experimental Usage
RES92440303,Nf1f/f;Trp53f/f;Nes-TK,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,Nf1f/f;Trp53f/f;Nes-TK,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,SKPs were isolated as previously reported from neonatal Nf1f/f;Trp53f/f;Nes-TK mice within 2 weeks of age,0.9,Accept,Experimental Usage
RESe1def87b,Nf1f/f;Trp53f/f;CGD,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,Nf1f/f;Trp53f/f;CGD,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,BC and DRG were harvested from the E13.5 embryos as described from Nf1f/f;Trp53f/f;CGD mice,0.9,Accept,Experimental Usage
RESd738ed2d,Nf1fl,,,Neurofibromatosis type 1,,,,,,,Nf1fl,PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Nf1 mice for conditional deletion (fl Zhu et al., 2001)",0.9,Accept,Experimental Usage
RESd995ff0b,Nf1/p53-/-,,,Neurofibromatosis type 1,Malignant peripheral nerve sheath tumors,,,,,,Nf1/p53-/-,PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Nf1/p53 cis mutant mice (− Cichowski et al., 1999)",0.9,Accept,Experimental Usage
RES53af612e,9a−/9a− Nf1,B6/129T2 hybrid,,Neurofibromatosis type 1,,,,,,,9a−/9a− Nf1,PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,Homozygous 9a−/9a− Nf1 mutants and wild-type (WT) littermates in the hybrid B6/129T2 background | crossing the obtained F1 mutant mice with each other to get homozygous 9a−/9a+ Nf1 mutants,0.9,Accept,Experimental Usage
RES635e34f6,Nf1fl/fl;DhhCre,C57Bl/6,,Neurofibromatosis type 1,Neurofibroma,,,,,,Nf1fl/fl;DhhCre,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,"by in-house breeding to Nf1 and fl/ + DhhCre to obtain Nf1 fl/fl ;DhhCre or Nf1 mice, as previously described",0.95,Accept,Experimental Usage
RESaff140e0,Nf2 flox2/flox2,FVB/N,,Neurofibromatosis type 2,Meningioma,,,,,,Nf2 flox2/flox2,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice",0.9,Accept,Experimental Usage
REScbe4b7bf,Nf2 flox2/flox2 ;p16 Ink4a*/*,FVB/N mixed strain,,Neurofibromatosis type 2,Meningioma,,,,,,Nf2 flox2/flox2 ;p16 Ink4a*/*,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice",0.95,Accept,Experimental Usage
RES51beed64,H7;Nf1mut,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,H7;Nf1mut,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The H7;Nf1mut mice have been described previously (10). Mice were maintained in a clean mouse facility...,0.9,Accept,Experimental Usage
RESb35d7371,Nf1flox/mut;GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/mut;GFAP-Cre,PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"Nf1 +/- GFAP CKO ( Nf1 flox/mut ;GFAP-Cre,  Nf1 -CKO) and littermate control ( Nf1 flox/flox ; CTL) mice were maintained on an inbred C57BL/6 background | Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described | while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established",0.95,Accept,Experimental Usage
RES3195007c,DhhCre,,,Neurofibromatosis type 1,Peripheral nerve sheath tumors,,,,,,DhhCre,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from murine peripheral nerve sheath tumors arising in DhhCre mice harboring Nf1-floxed alleles and Ink4a/Arf heterozygosity,0.85,Accept,Experimental Usage
RES167f736f,Nf1flox/flox;Arf flox/flox;PostnCre+,,,Neurofibromatosis type 1,,,,,,,Nf1flox/flox;Arf flox/flox;PostnCre+,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice,0.85,Accept,Experimental Usage
RES7a15e78d,Nf1flox/wt,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/wt,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage
RESc3e4f29b,Nf1flox/mut,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/mut,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage
RES027c26cd,Nf1flox/flox; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/flox; Olig2-Cre,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage
RESdab9bd29,Nf1flox/mut; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/mut; Olig2-Cre,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage
RES94bdb445,Nf1flox/flox; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/flox; Prom1-CreER,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage
RESfdb125d4,Nf1flox/mut; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/mut; Prom1-CreER,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage
RESa5ded38d,Periostin-CRE;NF2 fl/fl,,,Neurofibromatosis type 2,,,,,,,Periostin-CRE;NF2 fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Periostin-CRE mice were provided by S.Conway (Indiana University) and crossed with NF2 fl/fl animals (RIKEN Bioresource Research Centre) to make Periostin-CRE;NF2 fl/fl animals,0.9,Accept,Experimental Usage
RESd7bf5ba5,Periostin-CRE;NF2 fl/fl YAP fl/fl,,,Neurofibromatosis type 2,,,,,,,Periostin-CRE;NF2 fl/fl YAP fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,crossed with YAP fl/fl or TAZ fl/fl mice to generate Periostin-CRE;NF2 fl/fl YAP fl/fl (NF2 fl/fl YAP fl/fl -CRE+),0.9,Accept,Experimental Usage
RES59ac0b63,Periostin-CRE;NF2 fl/fl TAZ fl/fl,,,Neurofibromatosis type 2,,,,,,,Periostin-CRE;NF2 fl/fl TAZ fl/fl,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,"Periostin-CRE;NF2 fl/fl TAZ fl/fl (NF2 fl/fl TAZ fl/fl -CRE+) mice, respectively, resulting in additional deletion of YAP or TAZ",0.9,Accept,Experimental Usage
RES6f70c029,P0-CRE,,,Neurofibromatosis type 2,,,,,,,P0-CRE,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Schwann cell-specific NF2-null mice generated with the P0-CRE line and the sciatic nerve injury model have been described,0.85,Accept,Experimental Usage
RESe367efab,Postn-cre;Nf2f/f,,,Neurofibromatosis type 2,Schwannoma,,,,,,Postn-cre;Nf2f/f,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Postn-cre were crossed with floxed Nf2 gene (Postn-cre;Nf2f/f) as previously described.,0.95,Accept,Experimental Usage
RES8b607c44,DhhCre;Nf1f/f;Luciferase,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,,DhhCre;Nf1f/f;Luciferase,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,pNF tumors were generated in nude mice by transplanting tumor cells harvested from dorsal root ganglia with DhhCre;Nf1f/f;Luciferase configuration,0.85,Accept,Experimental Usage
RESc67bdf21,Tg(U6x:nf2a/b-4sgRNA),,,Neurofibromatosis type 2,,,,,,,Tg(U6x:nf2a/b-4sgRNA),PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center), Tg(HOTCre:Cas9) (a kind gift from Dr Wenbiao Chen, Vanderbilt University School of Medicine, Nashville, TN, USA), Tg(−7.2kb-sox10:mRFP) and Tg(U6x:nf2a/b-4sgRNA) (generated at the Bronner laboratory, Caltech) lines.",0.95,Accept,Development
RES18e0d32c,NF1 R1947X minipig,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,,NF1 R1947X minipig,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,"To generate a minipig model of NF1, we mimicked a recurrent nonsense mutation p.Arg1947X (R1947X) identified in 62 of 8100 (± 8) unrelated and symptomatic NF1 patients",0.95,Accept,Development
RESb3e83b3e,TetOff-Osx-/-Nf1,,,Neurofibromatosis type 1,pseudoarthrosis,,,,,,TetOff-Osx-/-Nf1,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,WT and Nf1 mice (herein called TetOff-Osx −/− Nf1 mice) were generated by crossing Osx −/− Nf1 flox/flox mice,0.9,Accept,Experimental Usage
RES75e5cd5b,Osx-/-Nf1flox/flox,,,Neurofibromatosis type 1,,,,,,,Osx-/-Nf1flox/flox,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"generated by crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice",0.85,Accept,Experimental Usage
RES0fabb727,"Osx-tTA,tetO-cre;Nf1flox/flox",,,Neurofibromatosis type 1,,,,,,,"Osx-tTA,tetO-cre;Nf1flox/flox",PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice ( 12 )",0.85,Accept,Experimental Usage
RES4be903d5,Nf2+/-,C57BL/6,C57BL/6J,Neurofibromatosis type 2,,,,,,,Nf2+/-,PMID:25877069 | PMID:24371224,10.1007/s11626-015-9885-z | 10.1158/0008-5472.CAN-13-2062,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line. | Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,"We generated SV40-immortalized cell lines derived from wild-type (WT) and neurofibromatosis 2 (merlin) heterozygote (Nf2+/-) mice, both on a commonly used genetic background, C57Bl/6J. | p16/p19+/− mice were crossed to Nf2 mice to obtain all of the genotypes used herein. All mice were in a comparable FVB genetic background",0.9,Accept,Experimental Usage
RESedb243f5,hGFAP-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,hGFAP-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
RESc5783883,Math1-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,Math1-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
RESc188abac,L7-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,,L7-cre,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage
RES58594ca6,Nestin-creER,,,Neurofibromatosis type 1,,,,,,,Nestin-creER,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,Tamoxifen inducible strain Nf1 NcreER CKO is described in later sections along with the tamoxifen administration protocol,0.9,Accept,Experimental Usage
RES70c2125d,Nf1-Arf flox/flox ;Postn-Cre,,,Neurofibromatosis type 1,,,,,,,Nf1-Arf flox/flox ;Postn-Cre,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues",0.9,Accept,Experimental Usage
RESbf0bcb00,CNP-HRas12V,,,Neurofibromatosis type 1,Schwann cell transformation,,,,,,CNP-HRas12V,PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,"we created a transgenic mouse model, CNP-HRas12V, expressing constitutively active HRas in Schwann cells",0.95,Accept,Development
RES7f9772df,NF1+/ex42del,Yucatan minipig,,Neurofibromatosis type 1,,,,,,,NF1+/ex42del,PMID:32193437,10.1038/s41598-020-61251-4,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,,"Here, we studied a NF1 minipig model (NF1+/ex42del) and 12 Yucatan minipigs (6 female, 6 male), 8 heterozygous for NF1 (NF1+/ex42del) and 4 littermate wildtypes",0.95,Accept,Experimental Usage
RES7c49a647,PeriCre(+);Nf1(flox/-),,,Neurofibromatosis type 1,"skeletal dysplasias, fracture non-union",,,,,,PeriCre(+);Nf1(flox/-),PMID:21980365,10.1371/journal.pone.0024917,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,,"This is replicated in two animal models of NF1, PeriCre(+);Nf1(flox/-) and Col2.3Cre(+);Nf1(flox/-) mice",0.9,Accept,Experimental Usage
RES5881c141,Col2.3Cre(+);Nf1(flox/-),,,Neurofibromatosis type 1,"skeletal dysplasias, fracture non-union",,,,,,Col2.3Cre(+);Nf1(flox/-),PMID:21980365,10.1371/journal.pone.0024917,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,,"This is replicated in two animal models of NF1, PeriCre(+);Nf1(flox/-) and Col2.3Cre(+);Nf1(flox/-) mice",0.9,Accept,Experimental Usage
RESadd174db,Nf1 flox/flox mice; α1(II) collagen-Cre,C57BL/6,,Neurofibromatosis type 1,Skeletal dysplasia,,,,,,Nf1 flox/flox mice; α1(II) collagen-Cre,PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,WT and Col2-Nf1 KO mice were generated by crossing Nf1 flox/flox mice and Nf1 flox/+ ; α1(II) collagen-Cre breeders,0.9,Accept,Experimental Usage
RESfc07422a,Osx-cre; Nf1 flox/flox,C57BL/6,,Neurofibromatosis type 1,Skeletal dysplasia,,,,,,Osx-cre; Nf1 flox/flox,PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,Osx-Nf1 KO mice were generated by breeding doxycycline-fed Osx-cre; Nf1 flox/flox mice with Nf1 flox/flox breeders,0.9,Accept,Experimental Usage
RES978912c9,Nf1 flox/- ; GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1 flox/- ; GFAP-Cre,PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,"( Nf1 flox/- ; GFAP-Cre ),  Nf1 +/-GFAP CKO  ( Nf1 flox/- ; GFAP-Cre; CD11b-TK ), CD11b-TK ( Nf1 +/-GFAP CKO-TK 22 )",0.9,Accept,Experimental Usage
RESc06d9b49,Nf1 +/- ;Cx3cr1+/GFP,C57BL/6,,Neurofibromatosis type 1,,,,,,,Nf1 +/- ;Cx3cr1+/GFP,PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,wild type (WT) and  Nf1 +/- ;Cx3cr1+/GFP  mice were all maintained on a C57BL/6 background,0.9,Accept,Experimental Usage
RES13dac434,NF1 exon a31 excision,,,Neurofibromatosis type 1,neurofibromas,,,,,,NF1 exon a31 excision,PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,3.83-year-old male NF1 pig harboring an NF1 exon a31 excision producing an alternatively spliced NF1 allele,0.9,Accept,Experimental Usage
RES87ed8d02,Nf1tm1Fcr,,,Neurofibromatosis type 1,,,,,,,Nf1tm1Fcr,PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Nf1 +/- mice were purchased from Jackson Laboratory (symbol Nf1 ) [ tm 1 Fcr 22 ],0.95,Accept,Experimental Usage
RES5610385e,C57BL6/J Nf1±; Trp53±cis,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,C57BL6/J Nf1±; Trp53±cis,PMID:36799629,10.1158/1078-0432.CCR-22-3722,MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.,,Murine MPNST JW23.3 cells were established previously from C57BL6/J Nf1±; Trp53±cis (NPcis) mice,0.9,Accept,Experimental Usage
RES02ec2a42,Dhh-Cre; Nf1(flox/flox),C57/129/FVBN,,Neurofibromatosis type 1,GEM grade I neurofibroma,,,,,,Dhh-Cre; Nf1(flox/flox),PMID:23099891,10.1007/s00401-012-1056-7,Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.,,"...PLX3397, a dual kit/fms kinase inhibitor that blocks macrophage infiltration, in the Dhh-Cre; Nf1(flox/flox) mouse model of GEM grade I neurofibroma...",0.95,Accept,Experimental Usage
RES6d726611,Nf1+/- C57Bl/6,C57BL/6,,Neurofibromatosis type 1,,,,,,,Nf1+/- C57Bl/6,PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,"We mated Nf1 +/− C57Bl/6 females ( Brannan et al., 1994 ) with Nf1 129X1/SvJ +/− Nf1 males",0.9,Accept,Experimental Usage
RES6737450f,Nf1 129X1/SvJ +/−,129X1/SvJ,,Neurofibromatosis type 1,,,,,,,Nf1 129X1/SvJ +/−,PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,"We mated Nf1 +/− C57Bl/6 females ( Brannan et al., 1994 ) with Nf1 129X1/SvJ +/− Nf1 males (Jackson; Bar Harbor, ME)",0.9,Accept,Experimental Usage
RESf32a9519,Hoxb7-cre Nf1 f/f,C57BL/6,,Neurofibromatosis type 1,Para-spinal neurofibroma,,,,,,Hoxb7-cre Nf1 f/f,PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,NPcis and Hoxb7-cre Nf1 f/f mice were rederived on C57bl/6 background,0.9,Accept,Experimental Usage
RESf38e5471,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj,C57BL/6,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj,PMID:37616542,10.1158/1535-7163.MCT-23-0258,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",,NPcis (B6;129S2-Trp53tm1Tyj Nf1tm1Tyj) transgenic mice were obtained from Jackson Labs,0.95,Accept,Experimental Usage
RES1902f508,P0-GGFβ3,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,,P0-GGFβ3,PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"The murine A202, B76 and B97 cell lines were established from MPNSTs arising in P 0 -GGFβ3 mice",0.85,Accept,Experimental Usage
RESbc516f0e,Nf2 flox/flox;Postn-Cre+,,,Neurofibromatosis type 2,schwannomatosis,,,,,,Nf2 flox/flox;Postn-Cre+,PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,Nf2 mice were generated in our laboratory as previously described (flox/flox;Postn-Cre+ (Nf2)),0.95,Accept,Experimental Usage
RESfea23225,P1 Nf1,iso31,,Neurofibromatosis type 1,,,,,,,P1 Nf1,PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,"Nf1, P1 Nf1, and UAS-P2 Nf1 lines were reported (Williams et al., 2001) and were outcrossed into an iso31 background for 7 generations.",0.85,Accept,Experimental Usage
RESfd21ac68,Nf1-/+;Trp53-/+cis,,,Neurofibromatosis type 1,,,,,,,Nf1-/+;Trp53-/+cis,PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,differences in astrocytoma and peripheral nerve sheath tumor susceptibility in Nf1-/+;Trp53-/+cis mice,0.95,Accept,Experimental Usage
RESd038a0d8,Nf1flox/flox; hGFAP-cre+,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/flox; hGFAP-cre+,PMID:16314489,10.1242/dev.02162,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,,mice genetically engineered to lack NF1 in CNS exhibit a variety of defects in glial cells,0.95,Accept,Experimental Usage
RESa3844810,Nf1flox/−; hGFAP-cre+,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,,Nf1flox/−; hGFAP-cre+,PMID:16314489,10.1242/dev.02162,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,,The mutant mice designated Nf1 include both hGFAP KO Nf1flox/−; hGFAP-cre+ and Nf1flox/flox; hGFAP-cre+,0.95,Accept,Experimental Usage
RESfcfb5e84,Krox20;Nf1flox/flox,,,Neurofibromatosis type 1,neurofibroma,,,,,,Krox20;Nf1flox/flox,PMID:18984156,10.1016/j.cell.2008.08.041,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,,"The Krox20;Nf1flox/flox mice and Krox20;Nf1flox/− mice have been previously described (Zhu et al., 2002).",0.9,Accept,Experimental Usage
RES125ea802,Krox20;Nf1flox/−,,,Neurofibromatosis type 1,neurofibroma,,,,,,Krox20;Nf1flox/−,PMID:18984156,10.1016/j.cell.2008.08.041,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,,"The Krox20;Nf1flox/flox mice and Krox20;Nf1flox/− mice have been previously described (Zhu et al., 2002).",0.9,Accept,Experimental Usage
